Cargando…
Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma
BACKGROUND: The exosomes contain many important proteins that can be used for early tumor diagnosis or patient prognosis analysis. In this study, we investigated plasma exosome-derived sentrin SUMO-specific protease 1 (SENP1) levels as a prognostic biomarker in patients with osteosarcoma. METHODS: T...
Autores principales: | Wang, Li, Wu, Jian, Song, Shu, Chen, Haining, Hu, Yong, Xu, Buwei, Liu, Jinbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006461/ https://www.ncbi.nlm.nih.gov/pubmed/33791211 http://dx.doi.org/10.3389/fonc.2021.625109 |
Ejemplares similares
-
Sentrin/SUMO Specific Proteases as Novel Tissue-Selective Modulators of Vitamin D Receptor-Mediated Signaling
por: Lee, Wai-Ping, et al.
Publicado: (2014) -
The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis
por: Chang, Che-Chang, et al.
Publicado: (2018) -
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
por: Burdelski, Christoph, et al.
Publicado: (2015) -
Author Correction: The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis
por: Chang, Che-Chang, et al.
Publicado: (2020) -
MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma
por: Jiao, Dan, et al.
Publicado: (2018)